These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21382904)

  • 41. Cardiac channelopathies in pediatric patients - 7-years single center experience.
    Illikova V; Hlivak P; Hatala R
    J Electrocardiol; 2015; 48(2):150-6. PubMed ID: 25554238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetics of sudden death: focus on inherited channelopathies.
    Cerrone M; Priori SG
    Eur Heart J; 2011 Sep; 32(17):2109-18. PubMed ID: 21478491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue.
    Ackerman MJ
    Heart Rhythm; 2015 Nov; 12(11):2325-31. PubMed ID: 26144349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Special issue on canine genetics: animal models for human disease and gene therapies, new discoveries for canine inherited diseases, and standards and guidelines for clinical genetic testing for domestic dogs.
    Shaffer LG
    Hum Genet; 2019 May; 138(5):437-440. PubMed ID: 31056728
    [No Abstract]   [Full Text] [Related]  

  • 45. Understanding and treating a channelopathy: severe myoclonic epilepsy of infancy.
    Krauss GL; Morrison PF
    Neurology; 2007 Jul; 69(3):233-4. PubMed ID: 17636058
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
    Charron P; Arad M; Arbustini E; Basso C; Bilinska Z; Elliott P; Helio T; Keren A; McKenna WJ; Monserrat L; Pankuweit S; Perrot A; Rapezzi C; Ristic A; Seggewiss H; van Langen I; Tavazzi L;
    Eur Heart J; 2010 Nov; 31(22):2715-26. PubMed ID: 20823110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Why do we need genetics in cardiac rhythmology?].
    Rieder M; Castiglione A; Asatryan B; Odening KE
    Herzschrittmacherther Elektrophysiol; 2020 Dec; 31(4):394-400. PubMed ID: 32661562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscle and brain sodium channelopathies: genetic causes, clinical phenotypes, and management approaches.
    Matthews E; Balestrini S; Sisodiya SM; Hanna MG
    Lancet Child Adolesc Health; 2020 Jul; 4(7):536-547. PubMed ID: 32142633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Session dedicated to neuromuscular channelopathies].
    Vallat JM
    Bull Acad Natl Med; 2014 Feb; 198(2):223-4. PubMed ID: 26263700
    [No Abstract]   [Full Text] [Related]  

  • 50. Inherited cardiomyopathies.
    Miles C; Fanton Z; Tome M; Behr ER
    BMJ; 2019 May; 365():l1570. PubMed ID: 31048310
    [No Abstract]   [Full Text] [Related]  

  • 51. Mind the Gap: Genetic Variation and Personalized Therapies for Cardiomyopathies.
    Zhang Y; MacCosham A
    Lifestyle Genom; 2018; 11(2):77-79. PubMed ID: 30231257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry.
    Migliore F; Biffi M; Viani S; Pittorru R; Francia P; Pieragnoli P; De Filippo P; Bisignani G; Nigro G; Dello Russo A; Pisanò E; Palmisano P; Rapacciuolo A; Silvetti MS; Lavalle C; Curcio A; Rordorf R; Lovecchio M; Valsecchi S; D'Onofrio A; Botto GL
    Europace; 2023 Aug; 25(9):. PubMed ID: 37536671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic testing in the contemporary diagnosis of cardiomyopathy.
    Sturm AC
    Curr Heart Fail Rep; 2013 Mar; 10(1):63-72. PubMed ID: 23135967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiomyopathy.
    Cruickshank S
    Nurs Stand; 2004 Feb 18-24; 18(23):46-52; quiz 54-6. PubMed ID: 15017816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The multifaceted cardiac sodium channel and its clinical implications.
    Chockalingam P; Wilde A
    Heart; 2012 Sep; 98(17):1318-24. PubMed ID: 22875823
    [No Abstract]   [Full Text] [Related]  

  • 57. [Human calcium channelopathies. Voltage-gated Ca(2+) channels in etiology, pathogenesis, and pharmacotherapy of neurologic disorders].
    Weiergräber M; Hescheler J; Schneider T
    Nervenarzt; 2008 Apr; 79(4):426-36. PubMed ID: 18210049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cardiac ion channelopathies: A potential link between cardiomyopathies and cardiac arrhythmias].
    Schimpf R; Rudic B; Tülümen E; Papavassiliu T; Dösch C; Borggrefe M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):591-7. PubMed ID: 23483420
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiology patient page. Patient's guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present.
    Tichnell C; James CA; Murray B; Tandri H; Sears SF; Calkins H
    Circulation; 2014 Sep; 130(10):e89-92. PubMed ID: 25210100
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuromuscular aspects of channelopathies with left-ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Finsterer J
    Pediatr Cardiol; 2012 Oct; 33(7):1235-6; author reply 1236-7. PubMed ID: 22706706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.